A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils

被引:116
作者
Fezoui, Y [1 ]
Hartley, DM
Walsh, DM
Selkoe, DJ
Osterhout, JJ
Teplow, DB
机构
[1] Harvard Univ, Sch Med, Dept Neurol Neurosci, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
[3] Rowland Inst Sci Inc, Cambridge, MA 02142 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/81937
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report here that a monomeric de novo designed alpha -helix-turn-alpha -helix peptide, alphat alpha, when incubated at 37 degreesC in an aqueous buffer at neutral pH, forms nonbranching, protease resistant fibrils that are 6-10 nn in diameter. These fibrils are rich in beta -sheet and bind the amyloidophilic dye Congo red. alphat alpha fibrils thus display the morphologic, structural, and tinctorial properties of authentic amyloid fibrils. Surprisingly, unlike fibrils formed by peptides such as the amyloid beta -protein or the islet amyloid polypeptide, alphat alpha fibrils were not toxic to cultured rat primary cortical neurons or PC12 cells. These results suggest that the potential to form fibrils under physiologic conditions is not limited to those proteins associated with amyloidoses and that fibril formation alone is not predictive of cytotoxic activity.
引用
收藏
页码:1095 / 1099
页数:5
相关论文
共 33 条
  • [1] Both oxidative stress-dependent and independent effects of amyloid β protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay
    Abe, K
    Saito, H
    [J]. BRAIN RESEARCH, 1999, 830 (01) : 146 - 154
  • [2] Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
    Booth, DR
    Sunde, M
    Bellotti, V
    Robinson, CV
    Hutchinson, WL
    Fraser, PE
    Hawkins, PN
    Dobson, CM
    Radford, SE
    Blake, CCF
    Pepys, MB
    [J]. NATURE, 1997, 385 (6619) : 787 - 793
  • [3] CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843
  • [4] Designing conditions for in vitro formation of amyloid protofilaments and fibrils
    Chiti, F
    Webster, P
    Taddei, N
    Clark, A
    Stefani, M
    Ramponi, G
    Dobson, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) : 3590 - 3594
  • [5] PURIFICATION AND CHARACTERIZATION OF A PEPTIDE FROM AMYLOID-RICH PANCREASES OF TYPE-2 DIABETIC-PATIENTS
    COOPER, GJS
    WILLIS, AC
    CLARK, A
    TURNER, RC
    SIM, RB
    REID, KBM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) : 8628 - 8632
  • [6] FEZOUI Y, 1995, PROTEIN SCI, V4, P286
  • [7] Dissection of the de novo designed peptide αtα:: Stability and properties of the intact molecule and its constituent helices
    Fezoui, Y
    Braswell, EH
    Xian, WJ
    Osterhout, JJ
    [J]. BIOCHEMISTRY, 1999, 38 (09) : 2796 - 2804
  • [8] DE-NOVO DESIGN AND STRUCTURAL CHARACTERIZATION OF AN ALPHA-HELICAL HAIRPIN PEPTIDE - A MODEL SYSTEM FOR THE STUDY OF PROTEIN-FOLDING INTERMEDIATES
    FEZOUI, Y
    WEAVER, DL
    OSTERHOUT, JJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 3675 - 3679
  • [9] An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments
    Fezoui, Y
    Hartley, DM
    Harper, JD
    Khurana, R
    Walsh, DM
    Condron, MM
    Selkoe, DJ
    Lansbury, PT
    Fink, AL
    Teplow, DB
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2000, 7 (03): : 166 - 178
  • [10] Solution Structure of alpha t alpha, a helical hairpin peptide of de novo design
    Fezoui, Y
    Connolly, PJ
    Osterhout, JJ
    [J]. PROTEIN SCIENCE, 1997, 6 (09) : 1869 - 1877